Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
Article (February 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Costimulatory receptors in the channel catfish: CD28 family members and their ligands
Article in Immunogenetics (January 2024)
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor
Article in Cancer Immunology, Immunotherapy (October 2023)